Summary
- Current Price
- As of today, CATX price is $3.91, up +3.58% in the most recent trading session on
- Current Price All-Time High
- CATX price is currently -95.41% below its historical high of $85.00 set on
- Market Cap
- CATX current market cap is $445M, up +143.89% over the past 365 days
- PE Ratio
- CATX PE ratio is unknown
- Revenue
- CATX current annual revenue is $884.00K, down -39.20% year-over-year
- Next Earnings
- The next earnings release for CATX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Perspective Therapeutics, Inc. |
| Ticker | NYSEAmerican: CATX |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | perspectivetherapeutics.com |
| Employees | 138 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $3.91 | ||
| Price, 1D Change | +3.58% | |
| $445M | ||
| - | ||
| - | ||
| 1.46 | ||
| $884K | ||
| Revenue, 1Y Change | -39.20% | |
| -$1.40 | ||
| EPS, 1Y Change | -13.53% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ISR | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.40 | ||
| EPS Estimate | N/A | -$1.19 |
| EPS Est. Change | N/A | +14.86% |
| $884.00K | ||
| Revenue Estimate | N/A | $363.31K |
| Revenue Est. Change | N/A | -58.90% |
| $3.91 | ||
| Price Target | - | $13.00 |
| Price Tgt. Change | - | +232.91% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| -$1.20 | -$1.40 | -16.80% | |
| -$1.19 | N/A | +14.86% | |
| -$1.15 | N/A | +17.54% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $11.18M | N/A | +668.91% | |
| $1.07M | $884.00K | -17.46% | |
| $363.31K | N/A | -58.90% | |
| $506.30K | N/A | -42.73% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +58.74% | ||
| -20.31% | ||
| +143.89% | ||
| +224.45% | ||
| -39.20% | ||
| -38.35% | ||
| -13.53% | ||
| +19.60% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $3.91 | ||
| $3.62 | ||
| SMA 200 vs Price | -7.31% | |
| $4.26 | ||
| SMA 50 vs Price | +9.13% | |
| 1.46 | ||
| $0.29 | ||
| 43.27 | ||
| 54.57% | ||
| 116.06% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $884.00K | ||
| -$1.40 | ||
| -$2.37M | ||
| -267.76% | ||
| -$103.56M | ||
| -11.72% | ||
| -$103.64M | ||
| -11.72% | ||
| -$100.31M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 5.17 | ||
| 5.17 | ||
| - | ||
| 1 | ||
| 1.54 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 720.63 | ||
| 1.28 | ||
| -1.68 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $207.03M | ||
| $144.74M | ||
| $274.35M | ||
| $148.39M | ||
| $67.31M | ||
| $28.68M | ||
| $3.25M | ||
| $679.00K | ||
| $20.51M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $104.52M | ||
| $101.20M | ||
| $3.25M | ||
| $0.00 | ||
| $3.25M | ||
| $0.00 | ||
| -$793.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$82.48M | ||
| $41.23M | ||
| $10.31M | ||
| $12.88M | ||
| -$95.37M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wedbush | → | |
| BTIG | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| UBS | → | |
| B. Riley Securities | → | |
| RBC Capital | → | |
| BTIG | → | |
| Piper Sandler |
Analyst sentiment
Institutional ownership
Screeners with CATX
FAQ
What is the ticker symbol for Perspective Therapeutics, Inc.?
The ticker symbol for Perspective Therapeutics, Inc. is NYSEAmerican:CATX
Does Perspective Therapeutics, Inc. pay dividends?
No, Perspective Therapeutics, Inc. does not pay dividends
What sector is Perspective Therapeutics, Inc. in?
Perspective Therapeutics, Inc. is in the Healthcare sector
What industry is Perspective Therapeutics, Inc. in?
Perspective Therapeutics, Inc. is in the Medical Devices industry
What country is Perspective Therapeutics, Inc. based in?
Perspective Therapeutics, Inc. is headquartered in United States
When did Perspective Therapeutics, Inc. go public?
Perspective Therapeutics, Inc. initial public offering (IPO) was on November 10, 2005
Is Perspective Therapeutics, Inc. in the S&P 500?
No, Perspective Therapeutics, Inc. is not included in the S&P 500 index
Is Perspective Therapeutics, Inc. in the NASDAQ 100?
No, Perspective Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Perspective Therapeutics, Inc. in the Dow Jones?
No, Perspective Therapeutics, Inc. is not included in the Dow Jones index
When was Perspective Therapeutics, Inc. last earnings report?
Perspective Therapeutics, Inc.'s most recent earnings report was on May 11, 2026
When does Perspective Therapeutics, Inc. report earnings?
The next expected earnings date for Perspective Therapeutics, Inc. is August 12, 2026
Data Sources & References
- CATX Official Website www.perspectivetherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/728387/000072838726000004/0000728387-26-000004-index.htm
- CATX Profile on Yahoo Finance finance.yahoo.com/quote/CATX
- CATX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/catx